Obexelimab in IgG4-Related Disease: INDIGO Trial Save
Dr. Henrique Dalmolin reports on abstract OP018 from the 2026 EULAR meeting in London.
By downloading this material, I acknowledge that it may be used only for personal use and personal education and that I will accredit RheumNow.com as the source and owner of this material. Commercial use or mass reproduction of this material without permission from RheumNow (info@rheumnow.com) is prohibited.
If you are a health practitioner, you may Login/Register to comment.
Due to the nature of these comment forums, only health practitioners are allowed to comment at this time.